BIOMAT Database Logo BIOMAT Database Logo

Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination. 1976

C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn

UI MeSH Term Description Entries
D008130 Lomustine An alkylating agent of value against both hematologic malignancies and solid tumors. CCNU,Belustine,Cecenu,CeeNU,NSC-79037,NSC 79037,NSC79037
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012673 Semustine 4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent. Methyl-CCNU,Me-CCNU,MeCCNU,NSC-95441,Me CCNU,Methyl CCNU,NSC 95441,NSC95441
D014750 Vincristine An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) Leurocristine,Citomid,Farmistin,Oncovin,Oncovine,Onkocristin,Vincasar,Vincasar PFS,Vincristin Bristol,Vincristin medac,Vincristine Sulfate,Vincrisul,Vintec,cellcristin,PFS, Vincasar,Sulfate, Vincristine

Related Publications

C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
Therapy of advanced gastrointestinal cancer with the nitrosoureas.
May 1973, Cancer chemotherapy reports. Part 3,
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
June 1976, Cancer treatment reports,
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
Epigenetic therapy in gastrointestinal cancer: the right combination.
July 2016, Therapeutic advances in gastroenterology,
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
Cancer chemotherapy with 5-fluorouracil alone and in combination with x-ray therapy.
October 1961, Cancer chemotherapy reports,
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
Radiation therapy alone or in combination with surgery in head and neck cancer.
May 1985, Cancer,
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas.
June 2019, DNA repair,
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
Oral fluoropyrimidine-based combination therapy in gastrointestinal cancer.
January 2001, Oncology (Williston Park, N.Y.),
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
Drug combination and repurposing for cancer therapy: the example of breast cancer.
January 2021, Heliyon,
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor.
October 2014, Molecular cancer therapeutics,
C G Moertel, and A J Schutt, and R J Reitemeier, and R G Hahn
In silico drug combination discovery for personalized cancer therapy.
March 2018, BMC systems biology,
Copied contents to your clipboard!